Baldness does not come from a single gene. The strongest genetic signal sits on the X chromosome, inside the androgen receptor gene you inherit from your mother, but large-scale studies have now identified more than 70 additional locations across the genome that contribute to hair loss. The old advice to “look at your mother’s father” captures a sliver of the truth while missing most of the picture, because roughly half of the known genetic risk for male pattern baldness comes from non-sex chromosomes inherited equally from both parents.
The X Chromosome and Your Mother’s Side
The single most powerful genetic contributor to male pattern baldness is the androgen receptor gene, which sits on the X chromosome. Because men get their only X chromosome from their mother, the variant of this gene you carry came entirely through her lineage. A massive genetic study of male pattern baldness confirmed that the androgen receptor was the top hit across the entire genome, and by a wide margin.1PubMed Central. Genetic prediction of male pattern baldness This is the kernel of truth behind the popular belief that baldness “comes from your mom’s dad.” If your maternal grandfather lost his hair early, there is a real biological reason to pay attention: the specific androgen receptor variant he carried could have passed through your mother to you.
The androgen receptor is the protein that detects androgens, a family of hormones that includes testosterone and its more potent derivative, dihydrotestosterone (DHT). Certain variants of the receptor make hair follicles on the scalp more sensitive to DHT, which gradually shrinks those follicles over time. Researchers have also explored whether the length of a repeating sequence within the androgen receptor gene (a string of repeating genetic “letters”) affects baldness risk, but findings have been mixed. One study found no meaningful difference in the length of these repeats between men with and without baldness.2PubMed Central. The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia A broader review noted that the same repeat length has shown conflicting associations across different studies, sometimes linked to androgenic traits, sometimes not.3PubMed. The CAG repeat polymorphism within the androgen receptor gene and maleness So while the androgen receptor gene on the X chromosome is clearly important, it is not a simple on-off switch, and researchers still do not fully understand which specific variations within it matter most.
The Other Half of the Story Lives on Non-Sex Chromosomes
If baldness were purely an X-chromosome trait, a man whose father went bald would have no elevated risk from that side of the family. But that is clearly not how it works in practice, and genetics has confirmed why. Studies have identified a second major risk location on chromosome 20, which you inherit from both parents in the usual way.4PubMed. Androgenetic alopecia: a review A genome-wide study found that men who carry risk variants at both the androgen receptor locus and this chromosome 20 locus, roughly one man in seven, face about a sevenfold increase in the odds of going bald compared to men who carry neither.5Nature Genetics. Male-pattern baldness susceptibility locus at 20p11
And chromosome 20 is far from the only non-sex chromosome involved. A large study of more than 70,000 men identified 71 independently confirmed genetic locations associated with male pattern baldness, together accounting for about 38% of the overall risk.6Nature Communications. GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk These loci are scattered across the genome, on chromosomes inherited from both parents. So while the androgen receptor gene gets the most attention, it is only the loudest voice in a choir of dozens. Your father’s genes contribute substantially to your risk, which is why a bald father really is a meaningful signal, regardless of what your mother’s father looked like.
How These Genes Lead to Hair Loss
Most of the genetic risk for baldness funnels through a single biological pathway. Testosterone circulates throughout the body, but in certain tissues an enzyme converts it into DHT, a hormone that binds the androgen receptor much more strongly. The version of this enzyme found in the scalp behaves differently from the version found elsewhere in the body; researchers have shown it has a different activity profile and requires far higher concentrations of testosterone to work at the same rate as the version in, say, the prostate.7PubMed Central. Identification and selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp This distinction matters because it explains why drugs targeting this enzyme can affect scalp hair without dramatically altering hormonal activity elsewhere.
When DHT binds to an androgen receptor in a susceptible hair follicle, it triggers a process called miniaturization. With each hair growth cycle, the follicle produces a thinner, shorter, lighter strand until it eventually stops producing visible hair altogether. The key word here is “susceptible.” Follicles on the sides and back of the head are largely resistant to DHT, which is why the classic horseshoe pattern of baldness spares those areas. The genetic variants scattered across those 71-plus locations influence different parts of this process: how much DHT gets made, how sensitive the receptor is, how the follicle responds to the hormonal signal, and how quickly miniaturization progresses.
Why the Back of Your Head Keeps Its Hair
One of the more interesting questions in baldness genetics is not why some men lose hair, but why the follicles at the back and sides of the scalp resist loss even when they sit in the same hormonal environment. Recent research points to epigenetic differences, meaning changes in how genes are read rather than changes in the genes themselves. Studies have found that the androgen receptor gene carries higher levels of a chemical modification called methylation in the follicles at the back of the head compared to those on top. This extra methylation appears to silence the receptor in those follicles, effectively shielding them from DHT’s effects.8PubMed. Genetic and molecular aspects of androgenetic alopecia
This finding has practical relevance: it is the reason hair transplant surgery works. When follicles from the back of the head are moved to a balding area, they bring their epigenetic protection with them and continue to grow in their new location. Their resistance to DHT is built into how those specific follicles read their DNA, not determined by where on the scalp they happen to sit.
There is also evidence that mechanical stress may play an underappreciated role in where baldness develops. One study found a strong correlation between the pattern of mechanical tension on the scalp, caused by the galea aponeurotica (a tough sheet of connective tissue stretching over the top of the skull), and the areas where hair loss occurs. The areas of highest tension matched the areas of greatest hair loss almost perfectly.9PubMed Central. Involvement of Mechanical Stress in Androgenetic Alopecia The proposed mechanism is that chronic mechanical strain triggers the same androgen-mediated signaling that shrinks follicles, creating a feedback loop between physical force and hormonal response. This is still an emerging area of research, and it does not replace the genetic explanation. Instead, it may help explain why specific follicles with genetic susceptibility go through miniaturization while others with the same DNA do not.
Female Pattern Hair Loss Has Different Genetic Roots
A common misconception is that female pattern hair loss is just a milder version of the same condition in men. The visible outcome can look similar, with thinning across the top of the head, but the underlying genetics appear to be meaningfully different. The genetic variants most strongly associated with male pattern baldness, including those at the androgen receptor locus, do not account for the pattern seen in women.10PubMed Central. Female Pattern Hair Loss: An Overview with Focus on the Genetics This means that having a father or grandfather who went bald is a less reliable predictor for women’s hair loss than it is for men.
Research into female hair loss has focused instead on other genetic pathways. One area of interest is the aromatase gene, which encodes an enzyme that converts androgens into estrogens within scalp follicles. This enzyme is expressed at different levels in balding versus non-balding scalps in women, and variations in the aromatase gene may influence susceptibility.11PubMed Central. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss In other words, while men’s baldness genetics center on how their follicles respond to androgens, women’s hair loss genetics may have more to do with how efficiently their follicles convert androgens into protective estrogens. The field is still working out the specifics, and far fewer large-scale genetic studies have been done on female hair loss compared to male.
Baldness Genetics Differ Across Populations
Almost everything we know about the genetics of baldness comes from studies of men of European descent. This is a real limitation, because genetic risk scores developed from European populations do a poor job predicting hair loss in men of African ancestry. One study tested two widely used European-derived genetic scores on African men and found they performed barely better than chance at distinguishing between men with and without hair loss. The scores worked reasonably well on a European cohort but fell apart when applied to a different population.12Human Genetics and Genomics Advances. Population-specific genetic architectures and the portability of polygenic predictions for androgenetic alopecia in sub-Saharan Africa
This does not mean the genetic principle is wrong. It means that different populations likely carry different sets of risk variants, or that the same variants have different effects depending on the broader genetic background. Rates of baldness do vary across populations in ways that are consistent with distinct genetic architectures. Researchers have also investigated whether these population differences could be explained by ancient interbreeding with Neanderthals, since Neanderthal DNA is present in people of European and Asian descent but largely absent in sub-Saharan African populations. The answer appears to be no: baldness-associated genetic regions in Europeans were not enriched for Neanderthal DNA compared to the rest of the genome.13PubMed Central. Uncovering the genetic architecture and evolutionary roots of androgenetic alopecia in African men Whatever drives the population differences, it is not leftover Neanderthal genes.
Why Evolution Has Not Eliminated Baldness
If baldness were purely disadvantageous from an evolutionary perspective, you might expect natural selection to have weeded out the responsible genes long ago, especially given how many of them there are and how common the trait is. Several hypotheses try to explain why it persists. One long-standing idea frames baldness as a signal of social maturity. In this view, the visual appearance of hair loss signals non-threatening social dominance, associated more with experience and wisdom than with physical aggression.14Ethology and Sociobiology. The evolutionary significance and social perception of male pattern baldness and facial hair Whether or not this provided a reproductive advantage is debatable, but the hypothesis fits with the observation that baldness tends to begin after peak reproductive years and progresses with age.
A more recent proposal, called the “Solar Window” hypothesis, suggests a possible metabolic benefit. The idea is that a bald scalp exposes more skin to sunlight, allowing greater production of vitamin D. This could be especially helpful in individuals who carry less efficient versions of the vitamin D receptor, essentially compensating for weaker receptors by increasing the raw supply of the vitamin. The hypothesis predicts that baldness might help maintain bone density later in life by boosting vitamin D synthesis.15Medical Hypotheses. The solar window hypothesis: androgenetic alopecia as an evolutionary adaptation to maintain bone mineral density in vitamin D receptor low-efficiency variants It is an intriguing idea, though it remains a hypothesis rather than an established finding, and it would need to be tested against actual data on bone density and baldness status in different climates.
There is also a simpler explanation: many baldness genes may persist simply because they do things unrelated to hair. When dozens of genes each contribute a small amount to hair loss risk, many of those genes likely have primary functions in other biological processes. Natural selection acts on the whole package of effects a gene has, not just on one trait. A gene variant that slightly increases baldness risk but also does something useful elsewhere in the body can easily stick around in the population.
Animal Models and Shared Genetics
Humans are not the only species that goes bald, and the animals that share this trait have been useful for understanding the underlying genetics. The stump-tailed macaque, a primate that develops a pattern of hair loss strikingly similar to human male pattern baldness, has been identified as a suitable biological model for the condition.16PubMed. Animal models for male pattern (androgenetic) alopecia Like humans, these macaques lose hair from the top of the head in an androgen-dependent fashion, while hair on the sides and back is preserved. The fact that a closely related primate develops the same pattern through the same hormonal pathway suggests that the genetic predisposition for baldness is ancient, predating the evolutionary split between humans and macaques.
Emerging Therapies Targeting the Genetic Pathways
Current treatments for baldness, primarily finasteride and minoxidil, work by either reducing DHT production or stimulating blood flow to follicles. They can slow hair loss and sometimes regrow hair, but they do not address the underlying genetic signals directly. A newer line of research focuses on a signaling pathway called Wnt/β-catenin, which plays a central role in hair follicle regeneration and the cycling of hair growth. Activating this pathway has been shown to promote hair follicle growth in laboratory and animal studies.17PubMed Central. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
In mouse models of androgenetic alopecia, treatment with stem cells derived from human umbilical cord tissue promoted hair growth and increased follicle density. The mechanism turned out to involve activation of the same Wnt/β-catenin pathway, essentially jump-starting the follicle’s growth program.18PubMed Central. Restoration of follicular β-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia Another approach uses tiny vesicles isolated from platelet-rich plasma, which similarly activated this signaling pathway and prolonged the active growth phase of hair follicles in laboratory culture.19PubMed Central. Platelet-rich plasma-derived exosomes stimulate hair follicle growth through activation of the Wnt/β-Catenin signaling pathway
None of these Wnt-based therapies has yet reached the point of being a standard clinical treatment for people. The jump from animal models and cell cultures to safe, effective human therapy is large. But the research signals a shift in how scientists think about baldness treatment: rather than just blocking the hormonal trigger, future therapies may try to reawaken the follicle’s own growth machinery. Given that dozens of genetic variants feed into the problem from different directions, treatments that target a shared downstream pathway like Wnt/β-catenin could theoretically help regardless of which specific combination of risk genes a person carries.
Can You Predict Your Own Risk?
Given everything researchers have mapped, you might wonder whether a genetic test could tell you reliably whether and when you will go bald. The honest answer is: not yet, and maybe not for a long time. The 71 known loci explain about 38% of the overall risk, which means more than half the genetic contribution remains unaccounted for. Environmental factors, hormonal variation, and the epigenetic differences discussed earlier add further unpredictability. The genetic risk scores that do exist work reasonably well in populations of European ancestry but, as the African population study showed, fall apart when applied across ancestries.12Human Genetics and Genomics Advances. Population-specific genetic architectures and the portability of polygenic predictions for androgenetic alopecia in sub-Saharan Africa
For now, your best rough prediction still comes from looking at your family, but from both sides, not just your mother’s. A bald maternal grandfather tells you something real about your X-linked risk. A bald father tells you something equally real about the autosomal half. If both sides show early hair loss, your cumulative genetic risk is higher than if just one side does. But even a strong genetic predisposition is not a guarantee, and some men with no obvious family history lose their hair, likely due to rare combinations of smaller-effect variants or de novo mutations. The genetics of baldness is genuinely complex, with many small contributions adding up rather than one gene calling the shots.